Need Some Help?
We can help you find the information that meets your research needs.
Please call us at
+886 2 27993110
+65 90752357
+60 12 7220722
or send an email to us at mi@hintoninfo.com
IHS_EWBIEEE xploreIHS_EWB_GF

HIP Reconstruction Devices Market - Global Forecast to 2020

  • LinkedIn
  • facebook
  • Twitter
Published: 2016/01/26
Page: 230
Format: PDF
Price:
USD 4,650 (Single-User License)
USD 5,650 (Multi-User License)
USD 9,000 (Global-User License)
線上訂購或諮詢
The global hip reconstruction devices market was valued at USD 4.8 billion in 2014 and is expected to reach USD 5.9 billion by 2020, at a CAGR of 3.0% from 2015-2020.

The purpose of this report is to cover the definition, description, and forecast up to 2020 of the global hip reconstruction devices market. It involves deep dive analysis of market segmentation which comprises of products and geography. The report also offers deep insights and strategic analysis of key players in the market. In this report, the hip reconstruction devices market is segmented on the basis of product. The global hip reconstruction devices market, by product is segmented into primary hip reconstruction devices, partial hip reconstruction devices, revision hip reconstruction devices and hip resurfacing devices. The primary hip reconstruction devices are subsegmented into cementless and cemented reconstruction device.

The hip reconstruction devices market has been segmented by geography, which includes major regions such as the Americas, Europe and Asia-Pacific. These regions are further segmented into the U.S., Canada, Mexico, Brazil, Argentina, Chile, Columbia, Uruguay and Paraguay. Similarly, the European region is further segmented into Germany, France, the U.K., Spain, Italy, The Netherlands, Switzerland, Belgium, Denmark, Turkey, and Russia. In Asia-Pacific, the major countries included are China, India, Japan, Australia, Republic of Korea, Singapore, Malaysia, New Zealand, Vietnam, Indonesia, Taiwan, and Thailand.

Globally, the North American region commanded the largest share in the hip reconstruction devices market in 2014. This can be attributed to rising pool of arthritis, favorable reimbursement, and technological advancements. Also, growing health awareness among masses, along with increase in the spending capacity of the population is propelling the market growth.

Furthermore, increasing number of population suffering from musculoskeletal disorders (MSD), government initiatives, and growing awareness towards hip reconstruction have accelerated the market growth. For instance, majority of the total hip replacement surgeries are performed for osteoarthritis in the Netherlands, and the numbers will substantially rise due to incidence of obesity, improving clinical outcomes of joint prosthesis, and increasing number of orthopedic surgeons. As per the National Public Health Compass report, the prevalence of osteoarthritis in the Netherland was 53.8 per 1,000 men, and 88.5 per 1,000 women in 2011. Around 17.6% of the population is 65 years and over, and is increasing the demand for implants. The number of total hip arthroplasties (THAs) performed per year in the Netherlands has been increasing in recent decades: from 1996 to 2005, the number of THAs increased from 16,803 to 20,281.

The report also provides a detailed competitive landscaping of companies operating in this market. The segment and country specific company shares, news & deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies would be detailed. The main companies operating in this market are Zimmer Inc. (U.S.), DePuy Synthes (U.S.), Stryker (U.K.), and Smith & Nephew (U.K.), B. Braun Melsungen AG (Germany), Corin (U.K.), and Waldemar LINK GmbH & Co. KG (Germany).


Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles. All these points put together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities in the hip reconstruction devices market.

The report provides insights on the following pointers:

‧ Product Analysis and Development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the global hip reconstruction devices market.
‧ Market Development: Comprehensive information about lucrative emerging markets is provided. The report also analyzes the markets for hip reconstruction devices across various regions, exploits new distribution channels, new clientele base, and different pricing policies.
‧ Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investment decisions in the global hip reconstruction devices market. Detailed description regarding the related and unrelated diversification pertaining to this market is also provided.
‧ Competitive Assessment: An in-depth assessment of market shares and company share analysis of the key players, which is forecast till 2020 is provided. The business strategies and manufacturing capabilities of leading players are offered for the major companies in the hip reconstruction devices market.
TABLE OF CONTENTS

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET SEGMENTATION & COVERAGE 20
1.3 STAKEHOLDERS 21
2 RESEARCH METHODOLOGY 22
2.1 RESEARCH METHODOLOGY-TRIANGULATION 23
2.2 ASSUMPTIONS 23
3 MARKET OVERVIEW: UNITED STATES 24
3.1 INTRODUCTION 25
3.2 BURDEN OF HIP RELATED AILMENTS (OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS) 26
3.3 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 26
3.4 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 27
4 MARKET OVERVIEW: CANADA 30
4.1 INTRODUCTION 31
4.2 BURDEN OF HIP RELATED AILMENTS (OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS) 32
4.3 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 33
4.4 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 34
5 MARKET OVERVIEW: MEXICO 37
5.1 INTRODUCTION 38
5.2 BURDEN OF HIP RELATED AILMENTS (OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS) 38
5.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 39
6 MARKET OVERVIEW: BRAZIL 42
6.1 INTRODUCTION 43
6.2 BURDEN OF HIP RELATED AILMENTS (OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS) 43
6.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 44
7 MARKET OVERVIEW: CHILE 47
7.1 INTRODUCTION 48
7.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 48
7.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 49
8 MARKET OVERVIEW: COLOMBIA 51
8.1 INTRODUCTION 52
8.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 52
8.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 53
9 MARKET OVERVIEW: ARGENTINA 56
9.1 INTRODUCTION 57
9.2 BURDEN OF HIP RELATED AILMENTS (OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS) 58
9.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 59
10 MARKET OVERVIEW: URUGUAY 62
10.1 INTRODUCTION 63
10.2 BURDEN OF HIP RELATED AILMENTS (OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS) 63
10.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 64
11 MARKET OVERVIEW: PARAGUAY 67
11.1 INTRODUCTION 68
11.2 BURDEN OF HIP RELATED AILMENTS (OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS) 68
11.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 69
12 MARKET OVERVIEW: GERMANY 72
12.1 INTRODUCTION 73
12.2 BURDEN OF HIP RELATED AILMENTS (OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS) 74
12.3 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 75
12.4 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 76
13 MARKET OVERVIEW: FRANCE 79
13.1 INTRODUCTION 80
13.2 BURDEN OF HIP RELATED AILMENTS (OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS) 80
13.3 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 81
13.4 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 82
14 MARKET OVERVIEW: U.K. 85
14.1 INTRODUCTION 86
14.2 BURDEN OF HIP RELATED AILMENTS (OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS) 87
14.3 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 87
14.4 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 88
15 MARKET OVERVIEW: SPAIN 91
15.1 INTRODUCTION 92
15.2 BURDEN OF HIP RELATED AILMENTS (OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS) 93
15.3 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 93
15.4 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 94
?
16 MARKET OVERVIEW: ITALY 97
16.1 INTRODUCTION 98
16.2 BURDEN OF HIP RELATED AILMENTS (OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS) 99
16.3 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 99
16.4 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 100
17 MARKET OVERVIEW: THE NETHERLANDS 103
17.1 INTRODUCTION 104
17.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 104
17.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 105
18 MARKET OVERVIEW: SWITZERLAND 108
18.1 INTRODUCTION 109
18.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 109
18.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 110
19 MARKET OVERVIEW: BELGIUM 113
19.1 INTRODUCTION 114
19.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 115
19.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 115
20 MARKET OVERVIEW: DENMARK 118
20.1 INTRODUCTION 119
20.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 119
20.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 120
21 MARKET OVERVIEW: TURKEY 123
21.1 INTRODUCTION 124
21.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 124
21.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 125
22 MARKET OVERVIEW: RUSSIA 128
22.1 INTRODUCTION 129
22.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 129
22.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 130
23 MARKET OVERVIEW: CHINA 133
23.1 INTRODUCTION 134
23.3 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 134
23.4 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 135
?
24 MARKET OVERVIEW: JAPAN 138
24.1 INTRODUCTION 139
24.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 140
24.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 140
25 MARKET OVERVIEW: INDIA 143
25.1 INTRODUCTION 144
25.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 145
25.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 145
26 MARKET OVERVIEW: REPUBLIC OF KOREA 149
26.1 INTRODUCTION 150
26.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 150
26.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 151
27 MARKET OVERVIEW: AUSTRALIA 154
27.1 INTRODUCTION 155
27.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 155
27.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 156
28 MARKET OVERVIEW: SINGAPORE 159
28.1 INTRODUCTION 160
28.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 160
28.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 161
29 MARKET OVERVIEW: NEW ZEALAND 164
29.1 INTRODUCTION 165
29.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 166
29.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 167
30 MARKET OVERVIEW: MALAYSIA 170
30.1 INTRODUCTION 171
30.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 172
30.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 173
31 MARKET OVERVIEW: VIETNAM 176
31.1 INTRODUCTION 177
31.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 177
31.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 178
?
32 MARKET OVERVIEW: INDONESIA 181
32.1 INTRODUCTION 182
32.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 182
32.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 183
33 MARKET OVERVIEW: TAIWAN 186
33.1 INTRODUCTION 187
33.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 187
33.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 188
34 MARKET OVERVIEW: THAILAND 191
34.1 INTRODUCTION 192
34.2 HIP RECONSTRUCTION SURGERIES: TRENDS FORECAST 193
34.3 HIP RECONSTRUCTION DEVICES: MARKET DYNAMICS 193
35 COMPETITIVE LANDSCAPE 196
35.1 AMERICAS: COMPANY SHARE ANALYSIS, TOP COUNTRIES 196
35.2 EUROPE: COMPANY SHARE ANALYSIS, TOP COUNTRIES 197
35.3 ASIA-PACIFIC : COMPANY SHARE ANALYSIS, TOP COUNTRIES 198
36 COMPANY PROFILES 199
36.1 CORIN 199
36.1.1 OVERVIEW 199
36.1.2 PRODUCT AND SERVICE OFFERINGS 199
36.1.3 RELATED DEVELOPMENTS 200
36.1.4 MNM VIEW 200
36.2 DEPUY SYNTHES 201
36.2.1 OVERVIEW 201
36.2.2 KEY FINANCIALS 202
36.2.3 PRODUCT AND SERVICE OFFERINGS 202
36.2.4 RELATED DEVELOPMENTS 203
36.2.5 MNM VIEW 203
36.3 DJO, LLC 204
36.3.1 OVERVIEW 204
36.3.2 KEY FINANCIALS 204
36.3.3 PRODUCT AND SERVICE OFFERINGS 205
36.3.4 RELATED DEVELOPMENTS 205
36.3.5 MNM VIEW 205
36.4 EXACTECH, INC. 206
36.4.1 OVERVIEW 206
36.4.2 KEY FINANCIALS 206
36.4.3 PRODUCT AND SERVICE OFFERINGS 207
36.4.4 RELATED DEVELOPMENTS 207
36.4.5 MNM VIEW 208
36.5 JAPAN MDM, INC. 209
36.5.1 OVERVIEW 209
36.5.2 KEY FINANCIALS 209
36.5.3 PRODUCT AND SERVICE OFFERINGS 210
36.5.4 RELATED DEVELOPMENTS 210
36.5.5 MNM VIEW 210
36.6 SMITH & NEPHEW 211
36.6.1 OVERVIEW 211
36.6.2 KEY FINANCIALS 211
36.6.3 PRODUCT AND SERVICE OFFERINGS 212
36.6.4 RELATED DEVELOPMENTS 212
36.6.5 MNM VIEW 213
36.7 STRYKER 214
36.7.1 OVERVIEW 214
36.7.2 KEY FINANCIALS 214
36.7.3 PRODUCT AND SERVICE OFFERINGS 215
36.7.4 RELATED DEVELOPMENTS 216
36.7.5 MNM VIEW 216
36.8 TORNIER, INC. 217
36.8.1 OVERVIEW 217
36.8.2 KEY FINANCIALS 217
36.8.3 PRODUCT AND SERVICE OFFERINGS 218
36.8.4 RELATED DEVELOPMENTS 219
36.8.5 MNM VIEW 219
36.9 UNITED ORTHOPEDICS CORPORATION 220
36.9.1 OVERVIEW 220
36.9.2 KEY FINANCIALS 220
36.9.3 PRODUCT AND SERVICE OFFERINGS 220
36.9.4 RELATED DEVELOPMENTS 221
36.9.5 MNM VIEW 221
36.10 ZIMMER, INC 222
36.10.1 OVERVIEW 222
36.10.2 KEY FINANCIALS 223
36.10.3 PRODUCT AND SERVICE OFFERINGS 223
36.10.4 RELATED DEVELOPMENTS 225
36.10.5 MNM VIEW 225
?
37 APPENDIX 226
37.1 CUSTOMIZATION OPTIONS 226
37.1.1 PRODUCT ANALYSIS 226
37.1.2 BRAND/PRODUCT PERCEPTION MATRIX 226
37.1.3 PORTER’S FIVE FORCES ANALYSIS 226
37.2 RT SNAPSHOT 227
37.3 RELATED REPORTS 228
Back